Triple-Negative Breast Cancers

Alana L. Welm, PhD, will receive the AACR Outstanding Investigator Award for Breast Cancer Research during this year’s San Antonio Breast Cancer Symposium.

Healio spoke with Eleonora Teplinsky, MD, about metastatic breast cancer and other challenging subtypes of breast cancer.

Healio spoke with Ahmed Elkhanany, MD, about where future research on metastatic triple-negative breast cancer should focus.

Healio spoke with Ahmed Elkhanany, MD, about racial disparities in metastatic triple-negative breast cancer.

The addition of pembrolizumab to first-line chemotherapy extended OS for certain patients with metastatic triple-negative breast cancer, according to topline data released by the agent’s manufacturer.